SUCNR1 抗体
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SUCNR1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| SUCNR1 抗体 (AA 100-149) | 人, 大鼠, 小鼠, Pig | 兔 Polyclonal |
|
|
|
| SUCNR1 抗体 (Middle Region) | 人, 马 | 兔 Polyclonal |
|
|
|
| SUCNR1 抗体 | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| SUCNR1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| SUCNR1 抗体 (AA 303-334) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| SUCNR1 抗体 (Center) | 人, 大鼠, 小鼠, Pig | 兔 Polyclonal |
|
|
|
| SUCNR1 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| SUCNR1 抗体 (AA 303-334) (FITC) | 人 | 兔 Polyclonal |
|
|
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠, 小鼠, Pig
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 100-149
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 马
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 303-334
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠, 小鼠, Pig
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Center
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 303-334
Latest Publications for our SUCNR1 抗体
: "A CD4+ T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate." in: Nature medicine, Vol. 25, Issue 1, pp. 75-81, (2019) (PubMed).
: "Succinate induces skeletal muscle fiber remodeling via SUNCR1 signaling." in: EMBO reports, Vol. 20, Issue 9, pp. e47892, (2019) (PubMed).
: "Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition." in: Biochemical and biophysical research communications, Vol. 495, Issue 4, pp. 2649-2656, (2018) (PubMed).
: "Macrophage-Derived Extracellular Succinate Licenses Neural Stem Cells to Suppress Chronic Neuroinflammation." in: Cell stem cell, Vol. 22, Issue 3, pp. 355-368.e13, (2018) (PubMed).
: "Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation." in: Oncotarget, Vol. 8, Issue 8, pp. 13174-13185, (2017) (PubMed).
: "Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis." in: Nature communications, Vol. 8, pp. 15621, (2017) (PubMed).
: "Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity." in: Diabetes, Vol. 64, Issue 4, pp. 1154-67, (2015) (PubMed).
: "The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells." in: International journal of molecular medicine, Vol. 36, Issue 1, pp. 130-8, (2015) (PubMed).
: "ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes." in: Molecular vision, Vol. 20, pp. 1109-21, (2014) (PubMed).
Aliases for SUCNR1 抗体
succinate receptor 1 (SUCNR1) 抗体succinate receptor 1 (Sucnr1) 抗体
GPR91 抗体
Gpr91 抗体